Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-01-18, Stock:JNJ, The news for the past five days is as follows:
2018-01-10: NEWS1: JNJ CEO: DACA important at a personal level.NEWS2: JNJ employee expresses gratitude to CEO Alex Gorsky for D....NEWS3: Health Care Sector Update for 01/10/2018: JNJ,ALKS,ADVL,APHN.NEWS4: The selloff in stocks today is nothing to worry about: NYSE trader.NEWS5: Stock Market News For Jan 10, 2018.NEWS6: Why JNJ's Stock Has Healthy Gains Ahead.NEWS7: Putting On The Brakes: Rally Takes Breather As Bond Yields Hit 10-Month High.NEWS8: Bayer and J&J win big, Microsoft lags because of Intel, Apple turns over information.NEWS9: Abbott Laboratories (ABT) Ex-Dividend Date Scheduled for January 11, 2018.NEWS10: AbbVie Inc. (ABBV) Ex-Dividend Date Scheduled for January 11, 2018.NEWS11: Alphabet’s Google Shows Fake News Can’t Win.NEWS12: Why AbbVie Wants Imbruvica to Be a Foundation Therapy in Hematologic Oncology.NEWS13: Stocks set to open in the red, judge dismantles Trump&apos;s plan to deport Dreamers.NEWS14: Bayer, J&J win reversal of $28 million verdict in Xarelto lawsuit.NEWS15: 3 Charts That Suggest Pharma Stocks Are a Buy in 2018.NEWS16: 3 Dividend Stocks Ideal for Retirees.NEWS17: Better Stock: AbbVie Inc (ABBV) vs. Johnson & Johnson (JNJ).NEWS18: How Incyte’s Jakafi Performed in 3Q17.NEWS19: Better Stock: AbbVie Inc (ABBV) vs. Johnson & Johnson (JNJ).NEWS20: 3 Dividend Stocks Ideal for Retirees.NEWS21: Don&apos;t Get Burned When a Stock Cuts Its Dividend.NEWS22: 3 Dividend Stocks That Cut Bigger Checks Than Johnson & Johnson.NEWS23: 3 Dividend Stocks That Cut Bigger Checks Than Johnson & Johnson.NEWS24: 3 Dividend Stocks That Are Perfect for Retirement.NEWS25: Stocks Rise Modestly As A Curious Trend Reemerges Ahead Of Earnings Season.
2018-01-11: NEWS1: Why TG Therapeutics Rallied 15.7% Today.NEWS2: Why TG Therapeutics Rallied 15.7% Today.NEWS3: Jeff Sessions is Taking Some Steam Out of the Marijuana Stocks Rally.NEWS4: Pharma's Tax-Cut Plans Look Pretty Dull.NEWS5: After a Solid Start, What Awaits Dow ETF in Q4 Earnings?.NEWS6: Trump looks to revamp major Medicaid requirements.NEWS7: Developments for Ionis Pharmaceuticals Post-3Q17.NEWS8: Recent Developments for Mylan.NEWS9: Jeff Sessions is Taking Some Steam Out of the Marijuana Stocks Rally.NEWS10: Health Care Sector Update for 01/11/2018: JNJ, PFE, ABT, MRK, AMGN, ARDM, MEIP, BSX, CRL, CRZ.CN, AQS.V.NEWS11: Big Pharma CEOs Speak About Impact of Tax Reform on M&A.NEWS12: 7 Must-See Numbers from AbbVie's J. P. Morgan Presentation.NEWS13: See what the IHS Markit Score report has to say about Johnson & Johnson..NEWS14: Big Pharma CEOs Speak About Impact of Tax Reform on M&A.NEWS15: Young immigrant who works for Johnson & Johnson pleads with lawmakers and CEO to save DACA.NEWS16: Young immigrant who works for Johnson & Johnson pleads with lawmakers and CEO to save DACA.NEWS17: Novartis Names Elizabeth Barrett CEO, Novartis Oncology - Quick Facts.
2018-01-12: NEWS1: Dow 30 Stock Roundup: Boeing Q4 Deliveries Up Y/Y, Success for Merck's Keytruda Combo.NEWS2: Abbott's (ABT) Diabetes Care Unit Strong on FreeStyle Libre.NEWS3: Pharma Stock Roundup: Novo Nordisk Reveals Bid to Acquire Ablynx, Pfizer & Others at Healthcare Conference.NEWS4: Abbott&apos;s (ABT) Diabetes Care Unit Strong on FreeStyle Libre.NEWS5: See what the IHS Markit Score report has to say about Johnson & Johnson..NEWS6: Wall Street Recommendations for Mylan in January 2018.NEWS7: Changes to Federal Tax Law Just What the Doctor Ordered for Healthcare Firms.
2018-01-16: NEWS1: Stocks Down, Energy Play Holds Firm; This Bitcoin ETF Finds 50-Day Support.NEWS2: Notable Tuesday Option Activity: AVXS, SSYS, JNJ.NEWS3: How Important Is Keytruda To Merck?.NEWS4: Health Care Sector Update for 01/16/2018: JNJ, PFE, ABT, MRK, AMGN, BNTC, EIGR, AVXS.NEWS5: See what the IHS Markit Score report has to say about Johnson & Johnson..NEWS6: Is Johnson & Johnson a Buy?.NEWS7: Is Johnson & Johnson a Buy?.
2018-01-17: NEWS1: U.S. court invalidates patent on J&J cancer drug Zytiga.NEWS2: &quot;Fast Money&quot; final trades: JNJ, INTC and more.NEWS3: Johnson & Johnson Issues Statement on ZYTIGA® Inter Partes Reviews.NEWS4: 7 More Dividend Stocks Benefiting From the Tax Cut.NEWS5: No More Tears: Johnson & Johnson Is Still in an Uptrend and Keeping Me Humble.NEWS6: Ortho-Clinical Diagnostics SA -- Moody's affirms Ortho-Clinical's ratings, outlook revised to stable.NEWS7: SPLG, JPM, JNJ, ORCL: ETF Inflow Alert.NEWS8: 7 More Dividend Stocks Benefiting From the Tax Cut.NEWS9: Kyprolis Could Boost Amgen’s Revenue Growth in 2018.NEWS10: 3 Dividend Stocks That Pay Out Over $8 Billion a Year.NEWS11: Zoetis Inc. (ZTS) Ex-Dividend Date Scheduled for January 18, 2018.NEWS12: Johnson & Johnson Aims to Start 2018 Healthy.NEWS13: 3 Dividend Stocks That Pay Out Over $8 Billion a Year.NEWS14: Johnson & Johnson Aims to Start 2018 Healthy.NEWS15: Amgen’s Xgeva Could Witness Revenue Growth in 2018.NEWS16: Exclusive: J&J attracts Chinese interest for diabetes business in potential $3-4 billion deal - sources.

Answer: Decrease